XML 124 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign

The sources of income before income taxes and equity in net earnings of affiliates were as follows for the years ended December 31, 2019, 2018 and 2017 (in millions):
 
2019
 
2018
 
2017
United States
$
(53.1
)
 
$
(126.0
)
 
$
(141.6
)
Foreign
314.2

 
486.3

 
425.4

Income before income taxes and equity in net earnings of affiliates
$
261.1

 
$
360.3

 
$
283.8



Schedule of Components of Income Tax Expense (Benefit)
The provision for income taxes by location of the taxing jurisdiction for the years ended December 31, 2019, 2018 and 2017 consisted of the following (in millions):
 
2019
 
2018
 
2017
Current:
 
 
 
 
 
United States:
 
 
 
 
 
Federal
$
(6.5
)
 
$
(9.1
)
 
$
20.3

State
2.1

 
1.2

 
0.6

Foreign
170.1

 
133.5

 
126.8

 
165.7

 
125.6

 
147.7

Deferred:
 
 
 
 
 
United States:
 
 
 
 
 
Federal
1.3

 

 
0.9

State

 

 

Foreign
13.8

 
(14.7
)
 
(15.0
)
 
15.1

 
(14.7
)
 
(14.1
)
 
$
180.8

 
$
110.9

 
$
133.6


Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of income taxes computed at the United States federal statutory income tax rate (21% for 2019, 21% for 2018 (from 35% to 21%), and 35% for 2017) to the provision for income taxes reflected in the Company’s Consolidated Statements of Operations for the years ended December 31, 2019, 2018 and 2017 is as follows (in millions):
 
2019
 
2018
 
2017
Provision for income taxes at United States federal statutory rate
$
54.8

 
$
75.7

 
$
99.3

State and local income taxes, net of federal income tax effects
(2.5
)
 
(6.0
)
 
(5.7
)
Taxes on foreign income which differ from the United States statutory rate
6.7

 
(0.3
)
 
(57.7
)
Tax effect of permanent differences
63.9

 
26.7

 
60.6

Change in valuation allowance
84.6

 
24.6

 
(1.4
)
Change in tax contingency reserves
3.2

 
8.5

 
3.8

Research and development tax credits
(7.1
)
 
(8.5
)
 
(5.0
)
Impacts related to changes in tax laws
(21.8
)
 
(8.4
)
 
42.0

Other
(1.0
)
 
(1.4
)
 
(2.3
)
 
$
180.8

 
$
110.9

 
$
133.6



Schedule of Deferred Tax Assets and Liabilities
The significant components of the deferred tax assets and liabilities at December 31, 2019 and 2018 were as follows (in millions):
 
2019
 
2018
Deferred Tax Assets:
 
 
 
Net operating loss carryforwards
$
72.0

 
$
74.5

Sales incentive discounts
61.9

 
58.8

Inventory valuation reserves
41.1

 
36.3

Pensions and postretirement health care benefits
51.6

 
47.6

Warranty and other reserves
128.5

 
98.6

Research and development tax credits
17.3

 
3.1

Foreign tax credits
6.4

 
9.7

Other
17.2

 
21.6

Total gross deferred tax assets
396.0

 
350.2

Valuation allowance
(169.1
)
 
(83.9
)
Total deferred tax assets
226.9

 
266.3

Deferred Tax Liabilities:
 
 
 
Tax over book depreciation and amortization
164.3

 
214.3

Investment in affiliates
50.3

 
42.8

Other
25.5

 
20.6

Total deferred tax liabilities
240.1

 
277.7

Net deferred tax liabilities
$
(13.2
)
 
$
(11.4
)
Amounts recognized in Consolidated Balance Sheets:
 
 
 
Deferred tax assets - noncurrent
$
93.8

 
$
104.9

Deferred tax liabilities - noncurrent
(107.0
)
 
(116.3
)
 
$
(13.2
)
 
$
(11.4
)

Summary of Income Tax Contingencies
A reconciliation of the beginning and ending balances of the total amounts of gross unrecognized tax benefits as of and during the years ended December 31, 2019 and 2018 is as follows (in millions):
 
2019
 
2018
Gross unrecognized income tax benefits at the beginning of the year
$
166.1

 
$
163.4

Additions for tax positions of the current year
32.8

 
3.8

Additions for tax positions of prior years
20.7

 
13.1

Reductions for tax positions of prior years for:
 
 
 
Changes in judgments
(4.6
)
 
(1.6
)
Settlements during the year
(0.7
)
 
(0.7
)
Lapses of applicable statute of limitations
(0.8
)
 
(4.4
)
Foreign currency translation
(2.8
)
 
(7.5
)
Gross unrecognized income tax benefits at the end of the year
$
210.7

 
$
166.1